Development of antisense oligonucleotides that enhance sIL7R as novel cancer immunotherapy

Project: Research project

Project Details

StatusFinished
Effective start/end date9/1/218/31/23

Funding

  • Autoimmunity Biologic Solutions, Inc.: $100,815.00